36
Chromosomal abnormalities Chromosomal abnormalities and tumors and tumors Seminar Seminar No 524, course: Cells and tissues No 524, course: Cells and tissues development development

Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Embed Size (px)

Citation preview

Page 1: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromosomal abnormalities Chromosomal abnormalities and tumorsand tumors

SeminarSeminar

No 524, course: Cells and tissues developmentNo 524, course: Cells and tissues development

Page 2: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Key words: chromosomal aberrations, translocation, amplification,double minutes,

HSR (homogenously staining regions), genotoxicity, DSB (double strand breaks), fused gene, LOH („loss of heterozygosity“), LOI („loss of imprinting“), chronic myelogenous leukemia (CML), Burkitt lymphoma (BL), retinoblastoma (RB), Wilms tumour (WT), syndromes with increase chromosome breakage = chromosomal instability syndromes: Bloom syndrome (BS), Fanconi anemia (FA), Ataxia teleangiectasia (AT), Xeroderma pigmentosum (XP), Nijmegen breakage syndrome (NBS), syndromes of prematury ageing: Werner syndrome, Cockayne syndrome

Page 3: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Structural chromosomal aberrations (CHA) =

result of unrepaired or misrepaired DNA damage =

early biological effect of genotoxicity

Late biological effect of genotoxicity = tumors

Primary event leading to CHA origin are double-strand breaks (DSB)

Page 4: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Primary changes connected with initiation of malignant process:

Rearrangement changing position of protooncogenes:

- abnormal activity of product

- abnormal gene expression

rearrangement only in tumor cells (chronic myelogenous

leukemia, Burkitt lymphoma)

Deletion of tumor suppressor genes

in tumor cells or constitutional aberrations (heterozygosity)

Page 5: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Primary changes connected with initiation of malignant process:

Translocations – 2 types of translocations

1. Translocations leading to fused genes (genes with function in cell

division regulation or differentiation)

Ph1 chromosome in chronic myelogenous leukemia (CML)

= reciprocal translocation 46,XX or XY,t(9;22)(q34;q11)

protooncogen abl is transfered from 9q to 22q near the gene bcr fused

gene bcr/abl abnormal product=chimeric protein with

increased tyrosinkinase activity

Ph1 in CML good prognosis

during blastic crisis - other chromosome changes

In B-ALL (acute lymphoblastic leukemia) other site of break in bcr

Ph1 in ALL = bad prognosis

Page 6: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Wysis katalog 1996/97

Fused gene brc/abldetected by FISH method in interphase cell

t 9/22

Page 7: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

2. Translocation of protooncogenes to the position, where they

are abnormally stimulated to transcription

Burkitt lymphoma (BL) –B lymphocytes

t(8;14)(q24;q32) also in other lymphomas

protooncogen myc transfered from 8q to 14q – near genes for heavy

chains of immunoglobulins abnormal stimulation of gene activity

abnormal amount of normal product

Other translocations: t(8;22) or t (2;8) – to neighbourhood of light

chains of immunoglobulins

T-lympho malignancies - breaks near genes for T-cells receptors

Page 8: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Translocation produces premalignant clone – probably other genetic

changes (mutations, epigenetic changes..) are necessary for full

malignancy

This changes (translocations, inversions

involving protooncogenes) are present only in

malignant or premalignant cells, it is not

constitutional change (present in all cells) !!!

Page 9: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Primary events:

Deletions of tumor suppressor genes

Retinoblastoma (Rb) – eye cancer of children

heritable type (familiar or „de novo“ origin) - AD (with reduced penetrance)

sporadic type – nonheritable

• familiar Rb – 1st step - germinal mutation or deletion in all cells of body =

heterozygote (constitutional abnormality)

2nd step : mutation in one cell of retina = loss of heterozygosity (LOH)

del(13)(q141-142)

• sporadic Rb – both mutations in one cell of retina

heterozygosity for mutation or deletion = predisposition to tumor

Page 10: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Retinoblastoma

heritable

sporadic

heterozygote

Mutation of second allele in one somatic cell = loss of heterozygosity

Mutation of both alleles consecutively in one somatic cell

→ →

Page 11: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Interstitial deletion 11p

Wilms tumor = nephroblastoma

WT1 locus on 11p13 mutation or deletion

isolated or a part of syndrome WAGR

association (Wilms, aniridia, urogenital

anomaly, mental retardation)

Page 12: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Deletion of one allele of tumor suppressor gene

can be constitutional aberration, present in alll

cells of body - heterozygote

Page 13: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Gain of material

Amplification of oncogenes:

„double minutes“ = amplified circular oncogenes (in solidtumors)

HSR (homogenously stainin regions) = amplification and recombination of oncogenes into

chromosome tandemly or into different sites

Amplification especially in solid tumors

Targeted therapy: Herceptin =monoclonal antibody against ERBB2 oncogene (=Her2/Neu= tyrosin-kinase receptor) in women with breast cancer and amplification of oncogene

Page 14: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Oncogene Her-2/neu amplification in breast cancer – FISH method

Page 15: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Tetraploid nucleus with amplification of Her2/neu

Page 16: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Trisomy and tetrasomy in cells of breast tumor

Page 17: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromosome loss in cells of breast tumor

Page 18: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Secondary changes – consequences of malignancy (genome instability in tumor cell):

Losses or gains of whole chromosomes, structural chromosomal rearrangements

Page 19: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

UroVysionBladder Cancer FISH Probe Panel CEP 3 (spektrum red) CEP 7 (spektrum green) CEP 17 (spektrum aqua) LSI p16 (spektrum gold) = 9p21- tumor suppressor gene (p16)

Page 20: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromosomal changes in bladder cancer cells – FISH method

(a) normal cell

(c) Homozygous 9p21 loss

(b) Trisomy 7

Page 21: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Karyotype of breast cancer cells from tissue culture – G-bands

Page 22: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Karyotype of breast cancer cells from tissue culture – G-bands

Page 23: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromosomal changes after radiotherapy, chemotherapy:

Breaks and rearrangements – detected in peripheral lymphocytes

Aberrations after irradiation - chromosome: dicentrics, tricentrics, chromosome breaks (on both chromatids), ring chromosomes

Aberrations after chemicals: – chromatid: chromatid breaks, chromatid exchanges

Page 24: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Dicentric chromosome + difragment

Aberrations after irradiation

Page 25: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Dicentric chromosome

Aberrations after irradiation

Page 26: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Ring chromosomes and difragments

Aberrations after irradiation

Page 27: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Aberrations after bleomycine (BLM) in vitro

BLM was added for the last 5 hours of cultivation

Page 28: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromatid breaks

Page 29: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromatid break

Page 30: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Multiple breaks

Page 31: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromatid exchange

Page 32: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromatid exchangeand breaks

Page 33: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Chromatid exchangeand breaks

Page 34: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Irradiated mouse cells in tissue culture

Page 35: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

Questions:• Explain why translocations in somatic cells sometimes lead to cancer? • What is Ph 1 chromosome?  • Can you describe cytogenetic manifestation of oncogene amplification?• Which chromosomal aberrations are primary events in malignancy?• Explain mechanisms of activation of protooncogene to oncogene. • Explain mechanisms of inactivation of alleles of tumor supressor gene. • Describe origin of heritable and sporadic retinoblastoma.• State expamples of malignancy connected with deletion of tumor suppressor gene.• Describe chromosomal abnormalities secondary to malignant process. • Describe translocation leading to origin of fused gene.• Describe translocation leading to abnormally increased synthesis of product.

 

Page 36: Chromosomal abnormalities and tumors Seminar No 524, course: Cells and tissues development

• What is the cause of Li Fraumeni syndrome?

• Describe chromosomal aberrations followed in peripheral lymphocytes of patients after chemotherapy, radiotherapy.

• What is the role of viruses in tumor origin?

• Describe difference between oncogene of DNA tumor viruses and RNA tumor viruses.